NCT07129538 Outcomes of Inspiratory Muscle Training in FMF Adolescents
| NCT ID | NCT07129538 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Familial Mediterranean Fever |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-10 |
| Primary Completion | 2025-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-05-10 with a primary completion date of 2025-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Familial mediterranean fever (FMF) is common to be diagnosed before age of 18 . this disorder is connected with deterioration in exercise tolerance, pulmonary capacities, fatigue tolerance,
Eligibility Criteria
Inclusion Criteria: * FMF adolecents * ages 13 -17 years * forty patients Exclusion Criteria: * cardiac problems * renal problems * liver problems * diabetes * brain problems
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07129538 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Familial Mediterranean Fever. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07129538 currently recruiting?
Yes, NCT07129538 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT07129538 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT07129538 clinical trial?
NCT07129538 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.